Skip to main content
Bin Wu, MD, Ophthalmology, Lancaster, MA

BinWuMD

Ophthalmology Lancaster, MA

Glaucoma Related, Retinal Disease

Physician

Are you Dr. Wu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 43 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    479 Old Union Tpke
    Lancaster, MA 01523
    Phone+1 978-537-3900
    Fax+1 978-537-6030

Summary

  • Dr. Bin Wu, MD is a board certified ophthalmologist in Lancaster, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Ohio, and Indiana. He is affiliated with UMass Memorial HealthAlliance-Clinton Hospital, Heywood Hospital, and UMass Memorial Medical Center.

Education & Training

  • Interfaith Medical Center
    Interfaith Medical CenterResidency, Ophthalmology, 1999 - 2002
  • Capital Health Regional Medical Center
    Capital Health Regional Medical CenterResidency, Internal Medicine, 1997 - 1998
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1996 - 1997
  • Hubei Medical University
    Hubei Medical UniversityClass of 1983

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2026
  • IN State Medical License
    IN State Medical License 2002 - 2015
  • OH State Medical License
    OH State Medical License 2005 - 2015
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Compulink Advantage EHR, Compulink, 2012-2014

Publications & Presentations

PubMed

Press Mentions

  • People with Viral Hepatitis Who Drink Alcohol Have Worse Outcomes
    People with Viral Hepatitis Who Drink Alcohol Have Worse OutcomesJune 10th, 2022
  • Dual Targeting of PD-L1 and PD-L2 by PCED1B-AS1 via Sponging Hsa-miR-194-5p Induces Immunosuppression in Hepatocellular Carcinoma
    Dual Targeting of PD-L1 and PD-L2 by PCED1B-AS1 via Sponging Hsa-miR-194-5p Induces Immunosuppression in Hepatocellular CarcinomaNovember 21st, 2020
  • Frontline Immune Checkpoint Inhibitors Cost-Effective for Advanced Melanoma
    Frontline Immune Checkpoint Inhibitors Cost-Effective for Advanced MelanomaAugust 7th, 2020
  • Join now to see all